ASX:ILAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Island Pharmaceuticals Ltd
$0.450
$0.010 (2.17%)
Day Range
$0.450 – $0.465
52 Week Range
$0.175 – $0.630
Volume
103.09K
Avg Volume (10D)
192.11K
Market Cap
$133.24M
Price Chart
Market Statistics
Open$0.460
Previous Close$0.460
Day High$0.465
Day Low$0.450
52 Week High$0.630
52 Week Low$0.175
Valuation
Market Cap133.24M
Shares Outstanding296.10M
Price to Book17.29
Trading Activity
Volume103.09K
Value Traded46.90K
Bid$0.450 × 322
Ask$0.455 × 661
Performance
1 Day-2.13%
5 Day3.37%
13 Week46.03%
52 Week124.39%
YTD6.98%
Technical Indicators
RSI (14)57.51
50-Day SMA$0.407
200-Day SMA$0.414
Latest News
Biotechnology
Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study
Island Pharmaceuticals expands USAMRIID CRADA to dose-optimise Galidesivir Marburg study; trials start next quarter; topline results H2 2026, a major milestone.
Biotechnology
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Island Pharmaceuticals strengthens US biodefence push with new adviser Mark Herzog, MC2 roles, and Galidesivir progress toward FDA Animal Rule trials.
Biotechnology
Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding
Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.
Biotechnology
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.